A detailed history of Catalyst Funds Management Pty LTD transactions in Embecta Corp. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,700 shares of EMBC stock, worth $35,411. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,700
Holding current value
$35,411
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.46 - $16.56 $19,482 - $28,151
1,700 New
1,700 $24 Million
Q2 2024

Dec 17, 2024

SELL
$10.13 - $14.6 $1,013 - $1,460
-100 Reduced 5.88%
1,600 $20 Million
Q1 2024

Dec 04, 2024

SELL
$12.35 - $19.33 $18,525 - $28,994
-1,500 Reduced 88.24%
200 $2.65 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.2B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.